Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-27 @ 11:31 PM
Study NCT ID:
NCT05430360
Status:
RECRUITING
Last Update Posted:
2025-02-17
First Post:
2022-06-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/recurrent Advanced Solid Tumors
Sponsor:
Grit Biotechnology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-04
First Submit QC Date:
None
Study First Post Date:
2022-06-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-13
Last Update Post Date:
2025-02-17
Last Update Post Date Type:
ACTUAL